Www.thno.org

Other immunotherapy. In a small-scale RCT on severe COVID-19, vilobelimab (anti-C5a antibody IFX-1) treatment did not show a therapeutic effect [92]. ... Therefore, hydroxychloroquine seems to have low value as a therapeutic agent for COVID-19. ... Mok TY, Chan JW, Hung I, Lam B, et al. High-dose pulse versus nonpulse corticosteroid regimens in ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download